44 CO-VAX, a biologic preparation targeting conditions of infections, in lung, and immune system, specifically in corona virus, COVID-19, SAR 1, and SAR 2, and MER virus
Trademark Events
Aug 18, 2021
Abandonment Notice E-Mailed - Failure To Respond
Aug 18, 2021
Abandonment - Failure To Respond Or Late Response
Feb 4, 2021
Notification Of Non-Final Action E-Mailed
Feb 4, 2021
Non-Final Action E-Mailed
Feb 4, 2021
Non-Final Action Written
Jan 22, 2021
Assigned To Examiner
Jul 16, 2020
New Application Office Supplied Data Entered In Tram